The Acute Treatment Response Test

Escapee cancer cells in the blood, or ‘CTCs’ as they are known, can be found by a simple blood test. A CTC Count test finds escapee cancer cells (CTCs) in a blood sample and counts them. The Acute Treatment Response test is a short series of two-three CTC counts taken before, during, and immediately after chemotherapy treatment. 

The immediate effect of chemotherapy on CTCs can now be measured. The Maintrac® Acute Treatment Response test can be used to:

  • Assess the immediate effects of therapies especially chemotherapy on a person’s CTCs
  • Monitor the acute treatment stage closely
  • Have confidence in the chosen treatment

Maintrac® is a state-of-the-art German technology that detects, characterises and tests CTCs. It has been critically validated and published in peer reviewed journals for over 12 years. Maintrac® CTC tests are acknowledged and utilised by many universities, Oncologists and cancer clinics worldwide.

The best way to monitor cancer activity and long-term effectiveness of treatment is via a single CTC count test every 3-6 months.



To order a test, download the order form and take it with you to the next appointment with your treating healthcare practitioner.